CLINICAL_TRIALS
trial_result
· 2017-04-07
Clinical Trial Update: 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma [EARLY_Phase 1]
Summary
Clinical trial update for an early-phase 1 study of the Ga-68 labeled PET tracer 68Ga-BNOTA-PRGD2 in glioma diagnosis and evaluation, sponsored by Peking Union …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Glioma | EARLY_Phase 1 | Status: UNKNOWN